MedPath

International Takotsubo Registry (InterTAK Registry)

Conditions
Takotsubo Cardiomyopathy
Registration Number
NCT01947621
Lead Sponsor
University of Zurich
Brief Summary

This is a multicenter, multinational, prospective and retrospective, observational study of patients with Takotsubo cardiomyopathy (TTC).

Data on natural profile (demographical characteristics, clinical phenotype, laboratory values, electrocardiography parameters, echocardiography parameters, coronary angiography parameters, medication) and outcome are systematically collected.

Our aim is to gain a better insight into the clinical profile and pathophysiology of TTC.

Detailed Description

Registry is an open-ended study and eligible individuals are assessed at index event and follow-up on their phenotypical characteristics. Furthermore, outcome data are collected (by clinical visits or telephone follow-up).

In addition, participants are given the option to consent to the donation of biosamples for the purposes to identify TTC specific biomarkers and mutations (sub-study on behalf of the registry).

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
4000
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Natural history of TTC10 years

To determine the natural history of Takotsubo cardiomyopathy.

Secondary Outcome Measures
NameTimeMethod
Cardiovascular complications, recurrence of TTC and all cause mortalityat hospitalizsation, short term (1 year) and long term (10 years)

Patients will be assessed for cardiovascular complications during hospitalisation and at follow-up (up to 10 years)

Trial Locations

Locations (1)

University Hospital Zurich, Division of Cardiology

🇨🇭

Zurich, ZH, Switzerland

© Copyright 2025. All Rights Reserved by MedPath